Risk factors for eczema in infants born in Cuba: a population-based cross-sectional study by Ramón Suárez-Medina et al.
Suárez-Medina et al. BMC Dermatology 2014, 14:6
http://www.biomedcentral.com/1471-5945/14/6RESEARCH ARTICLE Open AccessRisk factors for eczema in infants born in Cuba: a
population-based cross-sectional study
Ramón Suárez-Medina1*, Silvia Josefina Venero-Fernández1, Esperanza de la Mora-Faife1, Gladys García-García1,
Ileana del Valle-Infante1, Liem Gómez-Marrero1, Dania Fabré-Ortiz2, Hermes Fundora-Hernández1, Andrea Venn3,
John Britton3, Andrew W Fogarty3 and the HINASIC (Historia Natural de la Sibilancia en Cuba/National History of
Wheezing in Cuba) Study GroupAbstract
Background: There is a concern that allergic disease in childhood is higher than expected in Cuba. The aim of this
study was to determine the risk factors for eczema of infants aged 12–15 months living in Havana.
Methods: We used a cross-sectional epidemiological study design. Data on eczema symptoms and a wide range of
lifestyle factors were collected by researcher administered questionnaires.
Results: Data were collected on 1956 children (96% response rate), of whom 672 (34%) were reported as having had
eczema. Independent risk factors for eczema included young maternal age (adjusted odds ratio (OR) 0.98 per additional
year of age; 95% confidence interval (CI) 0.97-0.99), child’s weight (OR 1.13 per additional kg; 95% CI: 1.03-1.25), insect sting
allergy (OR 2.11; 95% CI: 1.33-3.35), rodents in the home (OR 1.39; 95% CI: 1.10-1.76), attendance at childcare facilities (OR
1.34: 95% CI: 1.05-1.70) and self-reported mould in the home (OR 1.23; 95% CI: 1.07-1.41). Infant exposure to paracetamol
was associated with an increased risk of eczema even after adjustment for wheeze (OR 1.22; 95% CI: 1.03-1.46).
Conclusion: Despite a very different culture and environment, the consistency of these findings with those from more
economically developed countries suggests potential causal associations. The association with paracetamol, even after
adjustment for wheeze, suggests that intervention studies are required in young infants, to ascertain if this commonly
used anti-pyretic medication increases allergic disease.
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Allergic disease is increasing globally [1], particularly in
countries where it was previously relatively rare [2], and
is most common in the more affluent, urbanised and eco-
nomically developed countries. However the aetiological
factors responsible remain unknown. It is likely that much
of the increase in allergic disease is the result of composite
exposures, probably starting in utero, which cause disease
in susceptible individuals [3]. Hence studies from the early
years of childhood are important in identifying risk factors
for subsequent development of common allergic diseases
such as eczema, which will aid our understanding of the
environmental exposures that result in allergic phenotypes.* Correspondence: ramonsm@inhem.sld.cu
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article, unless otherwise stated.One avoidable risk factor of particular interest in the
aetiology of allergic disease is use of paracetamol, which
has been shown to be associated with eczema in both
children and adults [4-7]. However, these associations
are potentially confounded by the use of paracetamol
to treat symptoms of respiratory infection, which are a
common manifestation of childhood asthma. It is there-
fore important to adjust for this confounding effect, to
determine whether paracetamol use and eczema are in-
dependently linked.
Cuba has a health care system that delivers infant
mortality rates comparable to much richer countries [8],
and deals well with common conditions that might
be misclassified as eczema. However, as a consequence
of the economic embargo on the island imposed by the
USA, societal development has been constrained. The
combination of good health infrastructure with limitedCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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unique environment that provides an ideal setting where
risk factors for disease can be studied utilising experienced
staff based in the network of policlinics that provide
healthcare to the whole population. As the pathogenetic
pathways that result in disease are likely to be consistent
across human populations, risk factors for allergic disease
from Cuba that are consistent with those identified in
more affluent countries are more likely to be real and not
simply artefacts due to confounding.
In the recent phase three of the International Study of
Asthma and Allergies in Childhood (ISAAC), Cuba had
one of the highest prevalences of eczema among the
countries studied from Latin America [9]. This study
concluded that ‘environmental risk factors must be eval-
uated in order to identify potential causes for the differ-
ences observed’. To address these issues, we have used a
cross-sectional study design to explore the risk factors




All children aged between 12–15 months who were liv-
ing in Havana, Cuba between March 2010 and March
2011 and who attended one of randomly selected 17
policlinics, nested in four municipalities in Havana,
Cuba were eligible to be selected to participate in the
study (Arroyo Naranjo, Cerro, Habana del Este, La
Lisa). Selection of the study population has been de-
scribed elsewhere [10]. The study protocol was ap-
proved by National Institute of Hygiene, Epidemiology
and Microbiology, the local Havana Scientific Commit-
tee and also by the University of Nottingham Medical
School ethics committee. All parents/guardians pro-
vided written informed consent for the infants to par-
ticipate in the study.
Data collection
The baseline data collection consisted of an interviewer
administered questionnaire (on-line Additional file 1)
that collated the responses from the parent/carer about
demographics of the child and mother, and a wide range
of prenatal and postnatal exposures of the child includ-
ing their living environment, the medical history of the
family, exposure to medications such as paracetamol, as-
pirin and antibiotics, and exposure to environmental to-
bacco smoke. Data on the height and weight at both the
time of birth and the interview were also collected. Al-
lergic disease outcomes were collected using the Spanish
translation of the ISAAC questionnaire [9,11] which was
piloted in the local community. The outcome of interest,
eczema, was based on the following question: ‘Does your
infant have or has had an itchy rash in any of thefollowing places: the folds of the elbows, behind the
knees, in front of the ankles, under the buttocks, or
around the neck, ears or eyes during the first year of
life?’ (¿Su bebé tiene o ha tenido erupción con picazón
en los siguientes lugares: sitio de flexión del brazo, atrás
de las rodillas, en las muñecas, debajo de las nalgas o
alrededor del cuello, orejas y ojos durante el primer año
de vida?). Data on insect sting allergy were collected
using the question “Has your baby been diagnosed with
insect sting allergy in the first year of life”.
Data analysis
All statistical analyses were carried out in Statav12
(StataCorp, Texas, USA) using the survey commands to
allow for the clustered survey design. Univariate ana-
lyses were initially performed using logistic regression.
Variables that were statistically significant in univariate
analysis (p ≤ 0.05) were then entered into a mutually
adjusted multivariable mode and a step-wise modelling
procedure followed to obtain a final model of only sta-
tistically significant (p ≤ 0.05) variables. Gender was
considered as a priori confounder. Associations of the
outcome with exposures that were continuous variables
were checked for linearity using likelihood ratio tests.
The presence of self-reported wheeze was considered
in the univariate analyses but omitted from the final
model, as this is another manifestation of allergic dis-
ease, which would result in overfitting.
Sample size
We aimed to collect data on 2000 children. In the first
year of life eczema is a better measure of allergic disease
than wheeze and we have used this for the primary
power calculation. We anticipate that we will have over
95% power (Epi-info, StatCalc) to detect an increase of
the odds ratio of eczema of 1.9 for those who receive
any paracetamol in the first year of life compared to
those who do not receive paracetamol conservatively as-
suming a baseline prevalence of eczema of 20% and that
10% of the children in the cohort will receive paraceta-
mol at some point in the first year of life.
Results
Of the 2032 infants who were eligible for inclusion in
the study, 1956 provided data giving a 96% response
rate. The characteristics of the study participants are
presented in Table 1 and the distribution of the risk fac-
tors of interest in Table 2. 672 (34%) infants were re-
ported as having had eczema symptoms in the first year
of life. This was strongly associated with other allergic
disease outcomes measured, including reported wheeze
(odds ratio (OR) 2.35, 95% confidence intervals (CI)
1.93, 2.85), asthma diagnosis (OR 1.97, 95% CI: 1.45-
2.67) and allergic rhinitis (OR 2.48, 95% CI: 2.00, 3.08).







Univariate OR for eczema (95% CI)
using survey commands
Mean age months, (sd) 13.1 (1.1) n/a 1.05 (0.91-1.20) per month
Skin colour (%) White 916 (47) 301 (33) 1
Mixed 798 (41) 282 (35) 1.12 (0.73-1.70)
Black 242 (12) 89 (37) 1.19 (0.82-1.73)
Gender (%) Female 939 (48) 301 (32) 1
Male 1017 (52) 371 (36) 1.22 (0.90-1.64)
Municipality (%) Habana del 642 (33) 240 (37) 1
Este
Cerro 374 (19) 81 (22) 0.46 (0.39-0.56)
La Lisa 282 (14) 109 (39) 1.06 (0.84-1.32)
Arroyo Naranjo 658 (34) 242 (37) 0.97 (0.80-1.19) p = 0.06
Highest educational status of mother (%) Primary 17 (1) 9 (53) 1
Secondary 431 (22) 159 (37) 0.52 (0.15-1.83)
Pre-university 1157 (59) 382 (33) 0.44 (0.10-1.88)
University 351 (18) 122 (35) 0.47 (0.17-1.31) p = 0.59 p(trend) = 0.18
Mother with paid work (%) No 780 (40) 264 (34) 1
Yes 1176 (60) 408 (35) 1.04 (0.72-1.51)
Household income pesos, (%) >3000 35 (2) 9 (26) 1
2000-3000 48 (2) 21 (44) 2.25 (0.69-7.34)
1001-1999 207 (11) 76 (37) 1.68 (0.41-6.81)
500-1000 955 (49) 335 (35) 1.56 (0.38-6.41)
<500 711 (36) 231 (32) 1.39 (0.42-4.55) p = 0.85 p(trend) = 0.44
Any siblings (%) No 818 (42) 297 (36) 1
Yes 1138 (58) 375 (33) 0.86 (0.63-1.18)
Mean age of mother at birth in years (sd) - 26.7 (6.2) n/a 0.98 (0.97-0.99) per year
Reported eczema No 1284 (66) n/a
Yes 672 (34)
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Table 1 and Table 2. In the multivariate analysis those vari-
ables identified as statistically significant independent risk
factors for eczema were young maternal age, increasing
child’s weight, family history of asthma, insect sting allergy,
attendance at childcare facilities, use of antibiotics, use of
preparations that contain paracetamol, mould in the home
and rodents in the home (Table 3).
The effect of maternal age was such that the risk of ec-
zema decreased by an estimated 2% for every additional
year of age of the mother. Similarly, a linear effect of
child’s weight at the time of the interview was seen, with
an estimated 13% increase in eczema risk per additional
kg in child’s weight; birthweight however was not associ-
ated with eczema. To investigate whether the observed
relationship between child’s paracetamol use and eczema
may be confounded by indication (children with eczema
more likely to experience respiratory symptoms whichmay be treated with paracetamol), we adjusted for symp-
toms of wheeze and this made little change to the asso-
ciation with paracetamol OR (1.22; 95% CI: 1.03, 1.46)).
The effect of antibiotics however did weaken when ad-
justed for wheeze in the first year of life, and was no lon-
ger statistically significant (OR 1.24; 95% CI 0.91, 1.69).
Discussion
Cuba is unique, having a high quality health infrastruc-
ture despite a weak economy that is limited by political
circumstance, which facilitates the delivery of high qual-
ity observational epidemiological studies in a relatively
poor country. To our knowledge, this is the first large
epidemiological study to explore the risk factors for
eczema in infants in Cuba in the 21st century, a country
that is known to have a very high, unexplained preva-
lence of symptoms of eczema in children [9]. We have
identified that insect sting allergy, family history of







OR for eczema using
survey command (95% CI)
Mother used paracetamol in pregnancy (%) No 1809 (92) 626 (35) 1
Yes 147 (8) 46 (31) 0.86 (0.43-1.73)
Mother used aspirin in pregnancy (%) Never 1778 (91) 596 (34) 1
Yes 178 (9) 76 (43) 1.48 (0.72-3.05)
Infant’s mean birth weight, kg, (sd) 3.34 (0.53) n/a 0.98 (0.84-1.13) per kg
Infant’s mean height at birth cm (sd)* 50.28 (2.38) n/a 1.02 (0.99-1.06) per cm
Infant’s mean weight, kg, (sd) 10.52 (1.56) n/a 1.14 (1.04-1.26) per kg
Infant’s mean height, cm (sd) 74.67 (3.72) n/a 1.02 (1.00-1.03) per cm
Caesarean birth (%) No 1163 (59) 394 (34) 1
Yes 793 (41) 278 (35) 1.05 (0.73-1.52)
Respiratory distress at birth (%) No 1836 (94%) 620 (34) 1
Yes 120 (6%) 52 (43) 1.50 (1.04-2.16)
Breastfeeding ≥4 months No 890 (45) 337 (38) 1
Yes 1066 (55) 335 (31) 0.75 (0.56-1.01)
Family history of asthma No 917 (47) 267 (29) 1
Yes 1039 (53) 405 (39) 1.56 (1.32-1.83)
Insect sting allergy (%) No 933 (48) 229 (25) 1
Yes 1022 (52) 443 (43) 2.35 (1.56-3.56)
Missing 1
Paracetamol use by infant including kogrip (%) No 1486 (76) 486 (33) 1
Yes 470 (24) 186 (40) 1.35 (1.12-1.62)
Antibiotic use by infant No 1255 (64) 363 (29) 1
Yes 696 (36) 307 (44) 1.94 (1.40, 2.68)
State of home (%) Good 1368 (70) 477 (35) 1
Regular 463 (24) 149 (32) 0.87 (0.77-1.01)
Poor 125 (6) 46 (37) 1.09 (0.40-2.98) p = 0.13 p(trend) = 0.84
No. of rooms in house (excluding bathroom
and kitchen)
1 246 (13) 91 (37) 1
2 540 (28) 167 (31) 0.76 (0.38-1.54)
≥3 1170 (60) 414 (35) 0.93 (0.44-1.99) p = 0.35 p(trend) = 0.83
Ventilation of home (%) Good 1535 (78) 524 (34) 1
Regular 307 (16) 102 (33) 0.96 (0.72-1.28)
Poor 114 (6) 46 (40) 1.31 (0.70-2.44) p = 0.62 p(trend) = 0.31
Presence of ornamental plants (%) No 1405 (72) 484 (34) 1
Yes 551 (28) 188 (34) 0.99 (0.77-1.26)
Presence of bathroom in home (%) No 255 (13) 96 (38) 1
Yes 1701 (87) 576 (34) 0.85 (0.59-1.22)
Mould in home (%) No 1385 (71) 443 (32) 1
Yes 571 (29) 229 (40) 1.42 (1.19-1.70)
Child sleeps in cooking area No 1774 (91) 592 (33) 1
Yes 182 (9) 80 (44) 1.57 (1.17-2.10)
Cook with gas (%) No 133 (7) 64 (48) 1
Yes 1823 (93) 608 (33) 0.54 (0.32-0.90)
Cook with electricity (%) No 1507 (77) 482 (32) 1
Yes 449 (23) 190 (449) 1.56 (0.99-2.45)
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Table 2 Univariate analysis of exposures and risk of eczema since birth (Continued)
Mosquito nets in home (%) No 728 (37) 240 (33) 1
Yes 1228 (63) 432 (35) 1.10 (0.83-1.47)
Air conditioning (%) No 1619 (83) 565 (35) 1
Yes 337 (17) 107 (32) 0.87 (0.72-1.05)
Infant’s room walls painted before birth No 953 (49) 321 (34) 1
Yes 1003 (51) 351 (35) 1.06 (0.85-1.32)
Infant’s room walls painted after birth No 1713 (88) 580 (34) 1
Yes 243 (12) 92 (38) 1.19 (0.66-2.16)
Infant’s mattress Used 1062 (54) 374 (35) 1
New 894 (46) 298 (33) 0.92 (0.67-1.26)
Infant sleeps alone No (not alone) 829 (42) 297 (36) 1
Yes (alone) 1127 (58) 375 (33) 0.89 (0.62-1.30)
Daily use of soap No 69 (4) 26 (38) 1
Yes 1887 (96) 646 (34) 0.86 (0.33-2.22)
Use of shampoo No 615 (31) 209 (34) 1
Yes 1341 (69) 463 (35) 1.02 (0.69-1.52)
No. of people in household 2 237 (12) 75 (32) 1
3 485 (25) 170 (35) 1.17 (0.54-2.49)
4 551 (28) 178 (32) 1.03 (0.50-2.14)
5 332 (17) 116 (35) 1.16 (0.74-1.83)
≥6 351 (18) 133 (38) 1.32 (0.63-2.74) P = 0.80 p(trend) = 0.20
Eats vegetables No 350 (18) 115 (33) 1
Yes 1606 (82) 557 (35) 1.08 (0.75-1.57)
Eats fruit No 184 (9) 65 (35) 1
Yes 1772 (91) 607 (34) 0.95 (0.49-1.85)
Maternal smoking during pregnancy No 1779 (91) 609 (34) 1
Yes 177 (9) 63 (36) 1.06 (0.67-1.67)
Mother currently smokes No 1557 (80) 513 (33) 1
Yes 399 (20) 159 (40) 1.35 (0.92-1.97)
Father currently smokes No 1309 (67) 434 (33) 1
Yes 647 (33) 238 (37) 1.17 (0.83-1.65)
Number of smokers in home 0 952 (49) 299 (31) 1
1 494 (25) 176 (36) 1.21 (0.90-1.62)
2 340 (17) 131 (39) 1.37 (0.86-2.17)
≥3 170 (9) 66 (39) 1.39 (0.89-2.15) P = 0.31 p(trend) = 0.03
Any grandparents smoke No 832 (43) 274 (33) 1
Yes 1124 (57) 398 (35) 1.12 (0.83-1.50)
Pets in home at time of birth No 1259 (64) 417 (33) 1
Yes 697 (36) 255 (37) 1.16 (0.70-1.93)
Pets in home now No 1239 (63) 419 (34) 1
Yes 717 (37) 253 (35) 1.07 (0.74-1.52)
Rodents in home No 1643 (84) 534 (32) 1
Yes 313 (16) 138 (44) 1.64 (1.33-2.02)
Cockroaches in home No 1432 (73) 470 (33) 1
Yes 524 (27) 202 (39) 1.28 (0.77-2.14)
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Table 2 Univariate analysis of exposures and risk of eczema since birth (Continued)
Air pollution near home No 1407 (72) 476 (34) 1
Yes 549 (28) 196 (36) 1.09 (0.57-2.08)
Child attended daycare/nursery No 1685 (86) 559 (33) 1
Yes 271 (14) 113 (42) 1.44 (1.14-1.83)
Any parasites** No 686 (96) 262 (38) 1
Yes 26 (4) 9 (35) 0.86 (0.23-3.21)
Any wheeze No 1084 (55) 280 (26) 1
Yes 872 (45) 392 (45) 2.34 (1.56-3.53)
*5 missing values.
**1244 infants were unable to provide a faeces sample for analysis.
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day-care attendance, a heavier current weight, having a
younger mother as independent risk factors for reported
symptoms of eczema in Havana. The association with
paracetamol is particularly interesting as it persisted
even after adjustment for wheeze, suggesting that this
was not simply confounding by association with respira-
tory infections. It is also of pragmatic importance since
exposure to paracetamol in this population, as in devel-
oped countries, was common.
Our data have a number of strengths that give us con-
fidence in the integrity of these observed associations.
In particular, the relatively large sample of almost 2000
infants with a response rate of 96% is excellent, and a
consequence of nesting the data collection within theTable 3 Multivariate analysis of exposures and risk of eczema
Variable Definition of category
Gender Female
Male
Infant’s mean current weight, per kg* -
Family history of asthma No
Yes
Insect sting allergy (%) No
Yes
Use of paracetamol No
Yes
Use of antibiotics No
Yes
Age of mother at birth (per year*) -
Rodents in home No
Yes




1937 individuals provided complete data for analysis.
*linear association.policlinics minimising inconvenience to the families and
staff involved. This reduces the risk of response bias and
also permits the associations observed to be generalised
to other similar populations. The study questionnaire
was developed by local epidemiologists who have much
experience of work with these populations and hence
allowed consideration of local factors that may be spe-
cific to these localities in the analysis. The data were col-
lected by highly trained health professionals who knew
the participants, thus enhancing the quality of the infor-
mation collected.
There are some limitations of our study design, which
are unavoidable. Cross-sectional study designs do not
allow causality to be attributed, and only associations to
be identified. However, the nature of the hypothesis wein first year of life
Number Adjusted OR for any eczema (95% CI)
1
1.09 (0.76-1.57)
10.52 (1.56) 1.13 (1.03-1.25)
917 (47) 1
1039 (53) 1.34 (1.04-1.73)
933 (48) 1
1022 (52) 2.11 (1.33-3.35)
1486 (24) 1
470 (76) 1.22 (1.02-1.46)
1
1.61 (1.10-2.34)
26.7 (6.2) 0.98 (0.97-0.99)
1643 (84) 1
313 (16) 1.39 (1.10-1.76)
1385 (71) 1
571 (29) 1.23 (1.07-1.41)
1685 (86) 1
271 (14) 1.34 (1.05-1.70)
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planation for the relationships that were observed. We
were unable to do any detailed measurements when the
infants were in utero, although we were able to collect
data on important exposures related to pregnancy such
as maternal smoking in pregnancy, weight and height at
birth, the mode of delivery and the duration of breast-
feeding. The use of the ISAAC questionnaire definition
of eczema allows comparison of our data with other
similar studies [11], but it is possible that this practical
epidemiological approach to defining the outcome meas-
ure may have a degree of imprecision as other causes of
itchy rashes in addition of eczema may be included in
the outcome measure. We are unable to exclude the
possibility of recall bias and residual confounding influ-
encing our data and the associations reported. Finally,
we have tested a number of exposures and hence are un-
able to exclude the possibility that some of the associa-
tions we observed are the consequence of chance.
There have been no comparable studies of eczema in
infants in Cuba, and so it is difficult to directly compare
our data with other study datasets. The third phase of
the ISAAC study had a limb in Havana and reported a
prevalence of having ever had a eczematous rash of 26%,
one of the higher prevalences in Latin America in chil-
dren aged six to seven years [9] with the data collected
in the latter half of the first decade of the 21st century.
A rash was reported to have first occurred below the
age of two years in 15% of these children, compared
to values of less than 1% in centres in Mexico. This is
compared to our prevalence of 34% of children having
symptoms of eczema in the first year of life in 2010. Ob-
viously these two prevalence estimates are not directly
comparable due to differences in definitions and recall
bias, but it is possible that eczema prevalence has in-
creased in young infants living in Havana over the first
decade of the 21st century.
This is the first study to report an association between
paracetamol exposure and eczema after adjustment for
symptoms of wheeze in young infants. The only other
dataset that studied the impact of paracetamol exposure
on incident eczema in 780 children aged between 1 and
3 years living in Ethiopia that adjusted for symptoms of
respiratory infections did not observe a similar associ-
ation [12], although the different ages prevent direct
comparison with our population, while the baseline ana-
lysis from the same study again did not observe an asso-
ciation with eczema with use of paracetamol [13]. Other
studies have reported that paracetamol is a risk factor
for eczema using analyses in older children from inter-
national datasets [4,6,7,14,15], and also data from a dif-
ferent population of Ethiopian children and adults from
the country reported an odds ratio of 1.9 for risk of self-
reported eczema in those taking more than three tabletsof paracetamol in the past month compared to those
who took none [5]. However, although plausible bio-
logical mechanisms exist that may possibly explain how
paracetamol exposure in early life can result in allergic
disease [15], it should be stressed that the role of para-
cetamol on the aetiology of allergic disease is conten-
tious and the likelihood is that a randomised controlled
trial will be required to resolve these issues.
Many of the other risk factors for symptoms of eczema
in our dataset have been previously reported and while
not novel, these give us confidence in the integrity of the
data collected and associations observed. Hence, it is
well known that a family history of asthma is a risk fac-
tor for allergic diseases such as eczema in children [16]
while the presence of mould in the home is also well
recognised to be associated with allergic disease [17].
We observed a strong association between a diagnosis of
insect sting allergy in the first year of life with eczema
symptoms that appears plausible in the light of other stud-
ies. One study population from Israel of 13 to 14 year old
schoolchildren reported an increased in both rate and se-
verity of allergic reactions to insect stings among those
with atopic diseases compared to those who did not have
atopic disease [18]. Similarly, a population-based study
from the USA reported that people with atopy experienced
anaphylaxis, an extreme form of allergic reaction more fre-
quently than people without atopy [19].
To our knowledge, the inverse association between
maternal age and risk of eczema has not been reported
previously [20-23]. Maternal age is closely related to
birth order as older mothers have more children, and
this is considered to be a risk factor for allergic disease,
with individuals with more elder siblings having less
hayfever and eczema [24]. Cord blood IgE is a risk factor
for development of atopic disease in childhood, and Scirica
reported that older mothers have lower levels of cord
blood IgE using data from 874 children from the USA [25],
an observation that is compatible with our data. The asso-
ciation between presence of rats in the home and eczema
is difficult to explain using the existing literature but we
speculate that this could be a surrogate marker for living
conditions or other exposures that we were unable to
measure.
Conclusion
In conclusion, we report that in infants born in Havana,
Cuba, insect sting allergy, family history of asthma, pres-
ence of rodents or mould in the house, daycare attend-
ance, a heavier current weight, use of paracetamol, and
having a younger mother are all independent risk factors
for reported symptoms of eczema. The delivery of high
quality observational epidemiological studies in a develop-
ing country is challenging for many reasons, but good data
from these environments are important as associations
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are more likely to be causal and not simply a consequence
of confounding, possibly by affluence. Cuba is a unique
developing country with excellent public health provision
and diagnostic ascertainment, and the consistency of these
findings with those from a range of more economically de-
veloped countries suggests that the risk factors identified
in our study may be important in the development of ec-
zema. The association with paracetamol, even after adjust-
ment for wheeze, suggests that intervention studies are
required in young infants, to ascertain if this commonly
used anti-pyretic medication increases allergic disease.
Additional file
Additional file 1: Study Questionnaire.
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